Increasing the Supply of Providers with a Drug Enforcement Agency Waiver to Treat Opioid Addiction in Rural America – Possible Effects of Permitting Physician Assistants and Nurse Practitioners to Prescribe Buprenorphine


This study will investigate the possible effects on rural access to treatment for opioid use disorder if Drug Enforcement Administration (DEA) waivers to prescribe buprenorphine as an office-based outpatient treatment for opioid addiction were available to Physician Assistants (PAs) and Nurse Practitioners (NPs). Better understanding of the potential additional workforce available to treat the devastating opioid use epidemic will allow policy makers to make informed decisions on expanding waiver eligibility.









Authors Title Type Date Documents/Media
Andrilla CHA, Coulthard C, Larson EH, Patterson DG, Moore TE Projected Contributions of Nurse Practitioners and Physicians Assistants to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas PUBLICATION 08-09-2018 Article
Andrilla CHA, Moore TE, Patterson DG, Larson EH Medication Assisted Treatment and the Rural Provider Workforce PRESENTATION 03-27-2018
Andrilla CHA, Moore TE, Larson EH, Patterson DG Projected contributions of nurse practitioners and physician assistants to buprenorphine treatment services for opioid use disorder in rural places PRESENTATION 05-10-2018